Mathematically modeling HIV drug pharmacodynamics

37 million people around the world today live with Human Immunodeficiency Virus (HIV), which is responsible for roughly 1.1 million deaths caused by AIDS-related conditions.

Detecting disease with a smartphone accessory

As antiretroviral drugs that treat HIV have become more commonplace, the incidence of Kaposi's sarcoma, a type of cancer linked to AIDS, has decreased in the United States. The disease, however, remains prevalent in sub-Saharan ...

New nanotechnique to deliver life-saving drugs to the brain

(Phys.org) —In a study published in today's issue of Nature Communications, researchers from FIU's Herbert Wertheim College of Medicine describe a revolutionary technique they have developed that can deliver and fully release ...

page 1 from 1

Antiretroviral drug

Antiretroviral drugs are medications for the treatment of infection by retroviruses, primarily HIV. When several such drugs, typically three or four, are taken in combination, the approach is known as highly active antiretroviral therapy, or HAART. The American National Institutes of Health and other organizations recommend offering antiretroviral treatment to all patients with AIDS. Because of the complexity of selecting and following a regimen, the severity of the side effects and the importance of compliance to prevent viral resistance, however, such organizations emphasize the importance of involving patients in therapy choices and recommend analyzing the risks and the potential benefits to patients without symptoms.

There are different classes of antiretroviral drugs that act at different stages of the HIV life cycle.

This text uses material from Wikipedia, licensed under CC BY-SA